| Term 
 
        | What is peripheral motor neuropathy? |  | Definition 
 
        | abnormal foot anatomy + increased pressure, callus formation and ulcers |  | 
        |  | 
        
        | Term 
 
        | What is peripheral sensory neuropathy? |  | Definition 
 
        | Lack of protective sensation=failure to sense injuries |  | 
        |  | 
        
        | Term 
 
        | What is peripheral autonomic neuropathy? |  | Definition 
 
        | DEficient sweating=cracked dry skin |  | 
        |  | 
        
        | Term 
 
        | What is neuro-osteoarthropathic deformities? |  | Definition 
 
        | similar to motor neuropathy, deformities lead to increased pressure (especially mild-plantar area) |  | 
        |  | 
        
        | Term 
 
        | What are the pathogen involved in infected ulcer, abx naiive (monomicrobial)? |  | Definition 
 
        | Beta-hemolytic strep/ S.aureus |  | 
        |  | 
        
        | Term 
 
        | what are pathogens involved in chronic ulcer, exposure to abx (polymicrobial)? |  | Definition 
 
        | S.aureus, Strep, Enterobacteriaceae |  | 
        |  | 
        
        | Term 
 
        | Pathogens involved in macerated ulcer from soaking (polymicrobial)? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Pathogens involved in nonhealing ulcer w/ prolonged abx exposure (polymicrobial, resistance)? |  | Definition 
 
        | S.aureus, CoNS, Enterococci, diphteroids, G- Rods, others |  | 
        |  | 
        
        | Term 
 
        | Pathogens extensive necrosis or gangrene (polymicrobial)? |  | Definition 
 
        | Mixed aerobic G+ cocci, G- Rods and anearobes |  | 
        |  | 
        
        | Term 
 
        | What needs to be present to consider infected? |  | Definition 
 
        | At least 2 of the followings: Warmth Erythema Tenderness Swelling Or, pus from ulcer site and/or nearby sinus tract   |  | 
        |  | 
        
        | Term 
 
        | Treatment for non-infected site? |  | Definition 
 
        | Provide supportive care  Ensure wound care Off-load local foot pressure Ensure proper footwear Optimize glycemic control Consult as needed, no Abc tx needed  evaluate & re-evaluate for healing |  | 
        |  | 
        
        | Term 
 
        | According to IDSA PEDIS 2 (mild infection) is? |  | Definition 
 
        | >=2 markers of inflammation w/ cellulitis/ erythema <= 2 cm around ulcer, limited to superficial; no systemic toxicity |  | 
        |  | 
        
        | Term 
 
        | According to IDSA PEDIS 3 (moderate infection) is? |  | Definition 
 
        | Features of mild infection & >=1 of the following: cellulitis > 2 cm around ulcer, lymphangetic streaking, spread beneath fascia, abscess, gangrene, involvement of bone or joint, muscle. |  | 
        |  | 
        
        | Term 
 
        | According to IDSA PEDIS 4 (severe infection)is ? |  | Definition 
 
        | Systemic toxicity or metabolic instability fever, chills, tachycardia, hypotension, confusion, acidosis, vomiting, severe hyperglycemia, azotemia |  | 
        |  | 
        
        | Term 
 
        | Tx mild 1st time infections? |  | Definition 
 
        | narrow spectrum Abx w/ good G+ activity (probably monomicrobial Staph or Strep) -Dicloxacillin PO - Clindamycin PO -Cephalexin PO  If chronis infx (polymicrobial & anaerobes): TMP-SMX PO, Augmentin PO (G+ & G-), Levo PO (some anaerobic, but not MRSA) |  | 
        |  | 
        
        | Term 
 
        | Treatment for moderate infections? |  | Definition 
 
        | TMP-SMX PO, Augmentin PO, Levo PO/IV, Cefoxitin 2nd GC IV, Ceftriaxone 3rd GC IM/IV, Ampicillin/ Sulbactam IV - Linezolid (MRSA) PO/IV/ + or - Aztreonam IV  - Daptomycin IV /+ or - Aztreonam IV - Ertapenem IV - Levo/ Cipro IV/PO + clinda IV/PO - Ticarcllin/ clavulanate or piperacillin/tazobactam IV - Cefuroxime 2nd GC IV/PO + or - metronidazole IV/PO  |  | 
        |  | 
        
        | Term 
 
        | Treatment of severe infection? |  | Definition 
 
        | Piperacillin/tazobactam IV, Levo/Cipro IV/PO + clinda IV/PO, Imipenem-cilastatin IV, Vanco & ceftazidime (pseudomonas coverage) (+ or - metronidazole (covers anearobes)) |  | 
        |  | 
        
        | Term 
 
        | Which type of osteomyelitis id the most prevalent? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Hematogenous osteomyelitis? (disease of childre <16 yo) |  | Definition 
 
        | Long bones predisposed: Femur, tibia, fibula, humerus, Vascular structure (sludging of blood at hairpins), less active phagocytosis Single pathogen mostly S. aureus  other based on risk fatcors:  Neonates: E.coli or grp B strep Elderly: (vertbra) E.coli 2nd to UTI  |  | 
        |  | 
        
        | Term 
 
        | Contiguous- spread osteomyelitis w/ vascular insufficiency predisposing factors? |  | Definition 
 
        | age >50, postoperative (hip fractures, soft tissue infx) |  | 
        |  | 
        
        | Term 
 
        | Contiguous- spread osteomyelitis w/ vascular insufficiency pathogens? |  | Definition 
 
        | Single or mutliple  S. aureus predominant pathogen  Other based on site:  Mandibular osteomyelitis-mixture of aerobic/ anaerobic oral flora  |  | 
        |  | 
        
        | Term 
 
        | What is the gold standard lab test for osteomyelitis? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Hematogenous emperic therapy? |  | Definition 
 
        | All IV: MRSA likely: New born: Vanco IV + 3rd gen Ceph IV (E.coli) Children: Vanco IV Adults: Vanco IV (if G- or anearobes vertebral (Ecoli) add another agent If MRSA unlikely: New born: Nafcillin IV + 3rd gen Ceph IV (cefotaxime, cefazidime, ceftizoxime, ceftriaxone) Children: Nafcillin IV (S.aureus) Adults: Nafcillin 2 g IV Q 4 h (S. aureus) Duration 6 wks, children 4 wks  |  | 
        |  | 
        
        | Term 
 
        | Tx if foot bone non-diabetic, d/t puncture wound? |  | Definition 
 
        | Cirpo, ceftazidime (alternative) treat for 6 wks  |  | 
        |  | 
        
        | Term 
 
        | Tx long bone (post fracture)? |  | Definition 
 
        | Vanco + ceftazidime Linezolid + ceftazidime (alternative) Treat for 6 wks  |  | 
        |  | 
        
        | Term 
 
        | Tx sternum (post op)-MRSA/MRSE likely? |  | Definition 
 
        | Vanco, linezolid (alt) Treat for 6 wks |  | 
        |  | 
        
        | Term 
 
        | Emperic tx Osteomyelitis w/ vacular insufficiency? |  | Definition 
 
        | Cover all:  MRSA- Vanco or linezolid MSSA- Cefazolin or nafcillin or ampicillin/sulbactam  Gram- bacilli include pseudomonas: 3rd gen ceph (ceftazidime) or cipro or levo  Anaerobes ( if foul smelling): Metronidazole or clinda (amp/sulb would also work) duration 6 wks  |  | 
        |  | 
        
        | Term 
 
        | PO abx for acute osteomyelitis (confirmed)? |  | Definition 
 
        | Children: amoxicillin, cephalexin, dicloxacillin Adults: PO FQ  |  | 
        |  | 
        
        | Term 
 
        | Who are candidates for PO outpatient? |  | Definition 
 
        | Children w/ good clinical response to IV Adults w/o DM or PVD Less likely to develop chronic osteomyelitis  |  | 
        |  | 
        
        | Term 
 
        | Limitation for PO cirprofloxacin? |  | Definition 
 
        | Poor coverage for anaerobes, staph, pseudomonas resistance high, not used in children <16/18 yo, not to be used in pregnancy |  | 
        |  | 
        
        | Term 
 
        | Advantages of PO Ciprofloxacin? |  | Definition 
 
        | Effective against G- bacilli (enterobacter, serratia) Avoids long term AMG /toxicities, effective in chronic osteomyelitis, 12 hr dosing schedule |  | 
        |  |